Casipong, Dionisio J.

HRN: 21-33-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/17/2022
05/24/2022
IV
600
Q6
Infected Wound
Waiting Final Action 
05/17/2022
CEFTRIAXONE 1G (VIAL)
05/17/2022
05/24/2022
IV
2g
IV
Infected Wound
Waiting Final Action 
05/20/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/20/2022
05/27/2022
TOPICAL
1%
OD
Infected Wound
Waiting Final Action 
05/23/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/23/2022
05/30/2022
IV
4.5g
Q8
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: